FDA grants accelerated approval pathway to voxelotor new drug application
By Julia Ernst, Ms Following the positive results of the HOPE Study at ASH Annual Meeting and Exposition, Global Blood Therapeutics announced it will submit a new drug application to the FDA for voxelotor through an accelerated approval pathway, according to a press release issued by the company. Voxelotor (GBT440,...
Recent Comments